Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

Andrew E. Teschendorff, Ahmad Miremadi, Sarah E. Pinder et al. · Genome biology · 2007 · 499 citations · Full text

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome

Anna Bergamaschi, Elda Tagliabue, Thérese Sørlie et al. · The Journal of Pathology · 2007 · 383 citations

Breast Oncology, Engineering, Pathology +17

The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors.

Elaine W. Raines, Timothy F. Lane, M. Luisa Iruela‐Arispe et al. · Proceedings of the National Academy of Sciences · 1992 · 361 citations

Cell Adhesion, Pdgf-b Chain, Immunology +19

SPARC (BM-40, Osteonectin) Inhibits the Mitogenic Effect of Vascular Endothelial Growth Factor on Microvascular Endothelial Cells

Christine Kupprion, Kouros Motamed, E. Helene Sage · Journal of Biological Chemistry · 1998 · 281 citations · Full text

SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor–stromal interactions

Norihiro Sato, Noriyoshi Fukushima, Naoki Maehara et al. · Oncogene · 2003 · 275 citations

Aberrant Methylation, Pancreatic Cancer, Epigenetic Regulation +11